Table 1 Associations between LINE-1 methylation levels and clinical–pathological characteristics
Characteristic | Group | N (%) | LINE-1 methylation, median in % (25th–75th percentiles) | p value |
|---|---|---|---|---|
Gender | Male | 28 (59.6) | 65.11 (58.66–67.09) | 0.978 |
Female | 19 (40.4) | 64.06 (58.54–71.21) | ||
Age at diagnosis | 0–< 2 years | 14 (29.8) | 66.47 (64.50–71.23) | 0.258 |
2–5 years | 24 (51.0) | 63.40 (58.32–67.17) | ||
> 5 years | 9 (19.2) | 61.28 (56.80–67.74) | ||
Stage | I | 11 (23.4) | 62.59 (57.12–66.27) | 0.281 |
II | 20 (42.6) | 64.80 (58.45–69.87) | ||
III | 16 (34.0) | 65.00 (63.14–71.28) | ||
Risk classification | Intermediate | 31 (66.0) | 65.23 (60.46–68.38) | 0.229 |
High | 16 (44.0) | 61.66 (57.35–67.27) |